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Background: Francisella infection attenuates immune cell infiltration and expression of selected pro-inflammatory
cytokines in response to endogenous LPS, suggesting the bacteria is actively antagonizing at least some part of the
response to Toll-like receptor 4 (TLR4) engagement. The ability of different Francisella strains to inhibit the ability of
E. coli LPS to induce a pulmonary inflammatory response, as measured by gene expression profiling, was examined
to define the scope of modulation and identify of inflammatory genes/pathways that are specifically antagonized
by a virulent F. tularensis infection.
Results: Prior aerosol exposure to F. tularensis subsp. tularensis, but not the live attenuated strain (LVS) of F.
tularensis subsp. holarctica or F. novicida, significantly antagonized the transcriptional response in the lungs of
infected mice exposed to aerosolized E. coli LPS. The response to E. coli LPS was not completely inhibited,
suggesting that the bacteria is targeting further downstream of the TLR4 molecule. Analysis of the promotors of
LPS-responsive genes that were perturbed by Type A Francisella infection identified candidate transcription factors
that were potentially modulated by the bacteria, including multiple members of the forkhead transcription factor
family (FoxA1, Foxa2, FoxD1, Foxd3, Foxf2, FoxI1, Fox03, Foxq1), IRF1, CEBPA, and Mef2. The annotated functional
roles of the affected genes suggested that virulent Francisella infection suppressed cellular processes including
mRNA processing, antiviral responses, intracellular trafficking, and regulation of the actin cytoskeleton. Surprisingly,
despite the broad overall suppression of LPS-induced genes by virulent Francisella, and contrary to what was
anticipated from prior studies, Type A Francisella did not inhibit the expression of the majority of LPS-induced
cytokines, nor the expression of many classic annotated inflammatory genes.
Conclusions: Collectively, this analysis demonstrates clear differences in the ability of different Francisella strains to
modulate TLR4 signaling and identifies genes/pathways that are specifically targeted by virulent Type A Francisella.Background
Francisella tularensis is a Gram-negative facultative
intracellular bacterium capable of causing severe disease
(tularemia) in humans. Type A (F. tularensis subsp
tularensis strains are highly virulent and associated with
a severe clinical course, particularly pneumonic tular-
emia, in North America. Type B (F. tularensis subsp* Correspondence: Kathie.Walters@systemsbiology.org
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strains, but is limited to Central Asia. F. novicida, some-
times considered another subspecies of F. tularensis, is
highly virulent in mice but a rare cause of human dis-
ease. The Centers for Disease Control has classified
Type A. F. tularensis as a Tier 1 select agent based on its
high infectivity and lethality, multiple routes of infection
and potential use in bioterrorism. The bacterium is con-
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10 organisms), and severe morbidity/mortality (up to
30 % mortality rate if untreated) [1, 2]. That combined
with the lack of an approved preventative vaccine against
pneumonic tularemia, as well as concerns about
antibiotic-resistant isolates, has led to renewed interest
in this pathogen.
The innate immune response represents the first-line
of defense against bacterial infection and plays a key role
in the initial pathogen detection and subsequent activa-
tion of adaptive immunity. Not surprisingly, bacteria
have evolved mechanisms to evade and perturb host
defense responses to facilitate their own replication and
this often correlates with the level of a pathogen’s viru-
lence. The fundamental molecular processes involved in
the extreme virulence of Type A F. tularensis are not
well understood but studies have demonstrated that it is
associated with an absence of a classic inflammatory
response. For example, F. tularensis fails to stimulate
production of pro-inflammatory mediators, including
TNF-α and IL12B (IL-12p40,) or activate dendritic cells
(DC) in the airways and lungs of aerosol-exposed mice
[3]. F. tularensis infection of mononuclear phagocytic
cells also fails to stimulate IFN-γ [4] or other cytokines
[5–7]. More recent studies have shown that inflamma-
some activation is suppressed during early Francisella
infection via targeting of TLR2-dependent signaling by
the bacterial gene FTL_0235 encoded protein [8]. Nu-
clear localization of the p65 subunit of NF-kβ was also
found to be partially inhibited by FTT031c, partially sup-
pressing pro-inflammatory cytokine responses in macro-
phages [9]. This inhibition was subsequently associated
with bacterial membrane-derived lipids [10]. However,
since much of this data was generated using in vitro in-
fection of cultured macrophages or dendritic cells (DC),
and often at very high multiplicity of F. tularensis expos-
ure, its relevance to biologically relevant air-borne Type
A F. tularensis in vivo infection is unclear as these infec-
tions are characterized by relatively low exposure dose
and involvement of multiple cell types present in the
lung. Furthermore, while the ability to replicate within
macrophages is generally associated with virulence [11],
F. tularensis mutants deficient in intramacrophage repli-
cation are not attenuated for virulence in the murine
model of pneumonic tularemia [12], suggesting that
pathogenesis is not exclusively linked to the bacteria’s
ability to antagonize macrophage activation and that in-
volvement and infection of other cell types is also
important.
Measuring changes in the expression levels of cellular
genes is a powerful tool to study pathogen-host interac-
tions and can yield important insights into how host cells
recognize bacteria and how bacteria manipulate host
biological processes to facilitate their own replication/dissemination. While studies have utilized transcriptional
profiling to characterize the absence of innate immune
gene expression during acute Francisella infection both
in vitro [13–15] and in vivo [16–19], none have investi-
gated the extent to which this is due to evasion of or
active antagonism of host defense response pathways. An
understanding of which inflammatory pathways are tar-
geted specifically by highly virulent F. tularensis will pro-
vide valuable information about bacterial pathogenesis as
well as provide insight into the complex regulatory net-
works governing inflammatory responses during bacterial
infection.
Toll-like receptor 4(TLR4) plays a key role in detecting
the presence of Gram (−) bacteria through recognition
of lipopolysaccharide (LPS) present on the surface of the
bacteria, initiating signaling cascades that culminate in
pro-inflammatory and interferon-inducible gene expres-
sion. Previous studies have shown that infiltration of
monocytes and activation of DCs in the lungs of mice
exposed to an aerosolized LPS is partially inhibited by
prior infection with Type A F. tularensis [3, 6] suggest-
ing that the bacteria is actively antagonizing at least
some part of the response to TLR4 engagement and sub-
sequent response. E. coli LPS-induced production of IL-
12B was also found to be partially suppressed in human
dendritic cells treated with membrane—derived lipids
from virulent, but not attenuated, Francisella, although
this required relatively high concentrations (30 ug/ml) of
lipids [10]. While inhibition of NF-kβ, IRF1 (interferon
regulatory factor 1) and IRF8 (interferon regulatory fac-
tor 8) activity has been linked to suppression of IL-12B
production [10], the molecular mechanism involved is
not clearly defined and the potential involvement of add-
itional immune-related transcriptional regulators re-
mains unknown. Moreover, these studies examined the
suppression of a limited number of inflammatory media-
tors and so the true extent of Francisella’s ability to
antagonize TLR4 signaling is not known.
Stimulation of TLR signaling culminates in the in-
duced expression of hundreds of genes [20–22]. Under-
standing which genes are specifically targeted by
Francisella will further help define the extent and mo-
lecular mechanisms of immune suppression. In the
current study, the ability of different Francisella strains
(F. tularensis subsp. tularensis SchuS4, Type B F. tular-
ensis subsp holarctica live vaccine strain (LVS), or
F.novicida) to modulate the pulmonary transcriptional
response to a TLR4 agonist was investigated using an
aerosol exposure mouse model. This provides a detailed
molecular portrait of the transcriptional response to a
TLR4 agonist in vivo to more clearly define the scope of
modulation and identify inflammatory genes/pathways
that are specifically antagonized by a virulent F. tularen-
sis infection.
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Bacteria
As described previously [23], Francisella tularensis sub-
species tularensis SchuS4 (CDC, Fort Collins, CO) was
grown to stationary phase with agitation at 37 °C in Muel-
ler Hinton broth supplemented with 2 % Isovitalex (BBL),
pelleted, suspended in PBS with 20 % glycerol, aliquoted,
and stored at −80 °C. The post-freeze titer of this stock
was 3 × 109 CFU/ml when cultured on cysteine heart agar
supplemented with 2 % hemoglobin. Francisella tularensis
subspecies holarctica live vaccine strain (LVS) was ob-
tained from Karen Elkins (FDA, Rockville, MD). Bacteria
were grown to stationary phase in Mueller Hinton broth
supplemented with 2 % Isovitalex, 1 % glucose, and 0.25 %
ferric pyrophosphate, washed, suspended in PBS with
20 % glycerol aliquoted and stored at −80 °C as previously
described [23]. The post-freeze titer of this stock was 4 ×
109 CFU/ml when cultured on modified Mueller Hinton
agar supplemented with 2 % hemoglobin and 1 % Isovita-
lex. F. novicida U112 strain (Francis Nano, University of
Victoria, Canada) was grown to stationary phase with agi-
tation at 37 °C in tryptic soy broth supplemented with
01 % L-cysteine, diluted in 20 % glycerol, aliquoted, and
stored at −80 °C. The post-freeze titer of this stock was
2 × 109 CFU/ml when cultured on tryptic soy agar supple-
mented with 0.1 % L-cysteine.Mice
Male and female BALB/c and C57BL/6 mice 8–10 weeks
of age and free of specific pathogens were purchased
from Jackson Laboratories (Bar Harbor, ME). Mice with
targeted deletions of myeloid differentiation response 88
(MyD88−/−) were kindly provided by Adeline Hajjar at
the University of Washington [57] This line was origin-
ally obtained from Shizuo Akira (Osaka, Japan) and had
been backcrossed at least 6 generations to C57BL/6 mice
[58]. Mice with targeted deletions of Toll/interleukin-1
receptor domain-containing adaptor inducing interferon
beta (TRIF−/−) also were originally obtained from S.
Akira and were backcrossed at least six generations to
C57BL/6 mice [59]. Mice were housed in laminar flow
cages and permitted ad lib access to sterile food and
water as previously described [23]. Animal studies were
conducted in compliance with the National Research
Council Guide for the Care and Use of Laboratory Ani-
mals. The mouse experiments were specifically approved
by the University of Washington Institutional Animal
Care and Use Committee, under protocol numbers
2671–06 and 2982–03.Mouse exposures and tissue harvests
Cohorts of mice (three to four animals/group) were ex-
posed to aerosolized bacteria in a whole animal exposurechamber with a computer interface to control pressures
and flows (Biaera Technologies, Frederick MD). As de-
scribed previously [23], aerosols were generated by mini-
Heart nebulizers with a flow rate of 8 L/min at 40 psi.
Dilution air was regulated at 11.5 L/min to maintain
total chamber flow at 19.5 L/min during a 10-minute ex-
posure. Aliquots of frozen bacteria stock (F. tularensis
subspecies tularensis (FT SchuS4), F. tularensis subsp.
holarctica (FT LVS), or F. novicida (FN)) were thawed
and diluted 1:4 in PBS for nebulization, targeting a lethal
dose for each strain. Actual bacterial deposition in the
lungs in each experiment was determined by quantita-
tive culture of homogenized lung tissue harvested from
three sentinel mice euthanized immediately after aerosol
exposure. Measured depositions for each pathogen were
as follows: F. tularensis subsp. tularensis (SchuS4) (242,
809, 74 CFU/lung), F. novicida (2827, 2673, 3805 CFU/
lung), F. tularensis subsp. holarctica (FT LVS) (1580,
1356, 1538 CFU/lung). Survival studies demonstrated
that the LD50s for aerosol exposure is less than
200 CFU/lung for FT SchuS4 and FN (Skerrett, unpub-
lished). The reported LD50 for FT LVS in Balb/c mice
infected by the aerosol route is approximately
1000 CFU/lung [60, 61]. Mock-infected control mice
were exposed to aerosolized PBS. To determine the ef-
fect of Francisella infection on responsiveness to LPS,
mice were exposed to aerosolized E. coli 0111:B4 LPS
(Ultrapure, List) at a concentration of 100 μg/ml 18 h
after inhalation of FT SchuS4, FT LVS, FN or PBS. After
2.5 h from the onset of LPS exposure, mice were eutha-
nized with pentobarbital and exsanguinated by cardiac
puncture. The pulmonary arteries were perfused with
5 ml cold PBS and the lungs homogenized in Qiazol ex-
traction solution. The infections and subsequent LPS ex-
posures were conducted once (3–4 animals/group) for
each Francisella strain.RNA isolation and expression microarray analysis
Total RNA was isolated from lung by homogenization
(10 % w/v) in Trizol (Invitrogen, Carlsbad, CA) followed
by chloroform extraction and isopropanol precipitation as
previously described [23] and RNA quality assessed using
a BioAnalyzer (Agilent Technologies, CA). Gene expres-
sion profiling experiments using Agilent Mouse Whole
Genome 44 K microarrays and data processing/analysis
was performed as previously described [23]. Briefly, fluor-
escent probes were prepared using Agilent QuickAmp
Labeling Kit according to the manufacturer’s instructions.
Spot quantitation was performed using Agilent’s Feature
Extractor software and all data entered into a custom-
designed database, SLIMarray (http://slimarray.systems-
biology.net), and then uploaded into Genedata Analyst 8.0
(Genedata, Basel, Switzerland). Data normalization was
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followed by relative normalization using pooled RNA
from mock infected mouse lung (n = 6) as reference. Tran-
scripts differentially expressed (at least 2-fold, p value
< 0.01) between infected and control animals were
identified by standard t test using the Benjamini-
Hochberg procedure to correct for false positive rate
in multiple comparisons. Ingenuity Pathway Analysis
and Entrez Gene (www.ncbi.nlm.nih.gov/sites) were
used for mammalian gene ontology and pathway
analysis.
Availability of data and materials
The complete microarray dataset has been deposited in
NCBI’s Gene Expression Omnibus [62] and is accessible
through GEO Series accession number GSE65871.
Quantitative RT-PCR
Quantitative real-time PCR was used to estimate Franci-
sella loads in lung tissue as previously described [23].
Reverse transcription of total lung RNA was performed
using either gene-specific primers or random primer and
the Superscript III First Strand cDNA synthesis kit (Invi-
trogen, Carlsbad, CA). Primers and probes used for de-
tection of Francisella were taken from [63].Results
Active suppression of the TLR4 signaling pathway is
specific to virulent Type A F. tularensis
BALB/c mice were first exposed to either aerosolized PBS,
Francisella tularensis subsp tularensis (FT SchuS4), the
live vaccine strain of Francisella tularensis subsp. holarc-
tica (FT LVS), or Francisella novicida (FN). Eighteen
hours after exposure to aerosolized bacteria or PBS, in-
fected and control animals were exposed to aerosolized E.
coli LPS, a potent TLR4 agonist. This time-point was
chosen based on a previous study showing a lack of induc-
tion of immune-related gene expression in the initial 24 h
post-exposure [23]. Lung samples were harvested 2.5 h
after LPS exposure to measure changes in the host tran-
scriptome using microarrays.
Each experiment compared 4 groups of mice: mice
exposed to aerosolized bacteria alone, mice exposed
to aerosolized bacteria followed 18 h later by expos-
ure to aerosolized LPS, mock infected mice exposed
to aerosolized PBS followed 18 h later by exposure
to aerosolized LPS, and mock infected control mice
exposed to aerosolized PBS alone. As shown in
Fig. 1a, exposure of mock-infected animals to
aerosolized E. coli LPS results in the increased ex-
pression (at least 2-fold increase in median expres-
sion level, p value < 0.01) of up to 1700 genes relative
to control animals exposed to aerosolized PBS alone,depending on the exposure. Very little change in E.
coli LPS-responsive genes occurred in the lungs of
animals exposed to either FT LVS (Fig. 1a, left panel)
or FT SchuS4 (Fig. 1a, right panel) alone. Animals
exposed to FN alone showed increased expression of
the majority of LPS-responsive genes, although gen-
erally at a lesser degree of change than observed in
E. coli LPS-exposed control animals (Fig. 1a, middle
panel). Purified F. novicida LPS neither stimulates
nor antagonizes signaling through murine TLR4, sug-
gesting that it does not directly interact with this re-
ceptor [24]. Furthermore, inhalation of F. novicida
LPS does not elicit an inflammatory response in vivo
[24]. Therefore, induction of LPS-responsive genes in
FN-infected lung tissue is unlikely to be mediated by
FN LPS engagement of TLR4.
Subsequent exposure of both FT LVS and FN-
infected animals to E. coli LPS resulted in increased
expression of LPS-responsive genes to levels gener-
ally similar to that seen in control animals exposed
to E. coli LPS (Fig. 1, left and middle panel, respect-
ively), suggesting that these strains do not actively
antagonize TLR4 signaling. Indeed, the expression
level of these genes in FN-infected, E.coli LPS-
exposed animals were generally higher than the
animals exposed to E. coli LPS alone. In contrast,
exposure of FT SchuS4-infected animals to E. coli
LPS did not result in extensive change in expression
levels of LPS-responsive genes (Fig. 1a, right panel).
The majority showed either no increase in expres-
sion or did not increase to levels comparable to
those observed in LPS-treated control animals. Sup-
pression of LPS-induced gene expression during FT
SchuS4 infection is unlikely to be directly related to
bacterial burden per se. FT SchuS4 and FT FN repli-
cate rapidly in murine lungs and FN was present at
higher concentrations than FT SchuS4 at the time of
analysis (Fig. 1b) and yet did not significantly impact
the transcriptional response to E. coli LPS. Further-
more, animals were exposed to a higher dose of FT
FN than FT SchuS4 (approximately 15 LD50s vs 5
LD50s, respectively). It is possible that the lack of
inhibition in the presence of FT LVS infection is
partly due to the lower level of replication in the
lungs of animals infected with this strain, resulting
in a bacterial burden that was approximately 100-
fold lower than that of FT SchuS4 (Fig. 1b), consist-
ent with a previous study [23]. Exposure of infected
animals to E. coli LPS did not appear to significantly
impact the replication level of any of the Francisella
strains. This data provides further molecular evi-
dence of a previous report demonstrating lack of im-
mune cell infiltration in the lungs F. tularensis-
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Fig. 1 Francisella-mediated antagonism of TLR4-mediated signaling correlates with strain virulence and not bacterial replication levels. a Heatmap
represents expression profiles of sequences that are regulated (at least 2-fold change in median expression level, p value < 0.01) in lung tissue in
response to aerosolized E. coli LPS. Each panel reflects separate exposure studies with BALB/c mice infected with either F novicida (FN), F. tularensis
subsp, holartica (LVS) or F. tularensis subsp. tularensis (SchuS4). Each column represents gene expression data comparing RNA from lung tissue
from an individual infected animal to pooled RNA isolated from mock animals (n = 6). Sequences shown in red represent increased expression.
Sequences shown in green represent decreased expression and sequences shown in black indicate no change in expression in treated relative to
control animals. b Replication levels of Francisella strains in lungs of Balb/c mice approximately 20.5 h post-infection as measured by qPCR of 16S
rRNA. Data represents mean and standard deviation of three individual animals
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K-means cluster analysis of the expression profiles of
E.coli LPS-inducible transcripts in lung tissue from con-
trol, FT SchuS4 infected and FT SchuS4-infected mice
challenged with E. coli LPS revealed three main groups
with distinct expression patterns. The first group in-
cluded sequences that were either not induced or
slightly induced (<3-fold) in FT SchuS4-infected alone
but highly induced in FT SchuS4-infected animals
subsequently challenged with E. coli LPS (Fig. 2a upper
panel and b, and Additional file 1: Table S1). The ex-
pression level of these sequences was either equivalentor even higher than that observed in mock animals chal-
lenged with E.coli LPS and so were designated “not sup-
pressed” by FT SchuS4. The second group included
sequences that were either not induced or not signifi-
cantly (<3-fold) induced in FT SchuS4 alone but were
more highly induced in FT SchuS4-infected animals sub-
sequently challenged with E. coli LPS (Fig. 2a middle
panel and c, Additional file 2: Table S2). While exposure
of FT SchuS4-infected animals to E. coli LPS did induce
expression of these sequences to a level generally higher
than was observed in FT SchuS4-infected animals, the
levels were generally still lower relative to E.coli LPS-
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100100 0
Fold change
Fig. 2 Differential effect of F. tularensis SchuS4 infection on E. coli LPS-responsive gene expression. a Expression profiles of LPS-responsive sequences
that are not suppressed (upper panel), partially suppressed (middle panel) or suppressed (lower panel) by prior FT Schu4 infection. Each column
represents gene expression data from an individual experiment comparing RNA from lung tissue from an infected animal to pooled RNA isolated from
mock animals (n = 6). Sequences shown in red represent increased expression, sequences shown in green represent decreased expression and
sequences in black indicate no change in expression in treated relative to control animals. Bar graphs represent expression levels (measured by
microarray) of individual LPS-responsive genes that were not suppressed (b) partially suppressed (c) or suppressed (d) by prior FT SchuS4 infection.
Data represents mean fold-change and standard deviation of two or three individual animals relative to control animals. Only sequences that were
3-fold induced (p value < 0.01) in all three LPS-exposed control animals (n = 978) were used for this analysis
Walters et al. BMC Genomics  (2015) 16:874 Page 6 of 16designated “partially suppressed”. Lastly, transcripts that
were not induced in either FT SchuS4 or FT SchuS4-
infected animals challenged with E. coli LPS (Fig. 2a
lower panel and d, Additional file 3: Table S3) were des-
ignated “suppressed”.
Overall, approximately two thirds of E. coli LPS-
inducible transcripts were either partially or completely
suppressed by prior Francisella infection, suggesting
significant antagonism of TLR4 signaling. However, the
differential effect on LPS-responsive gene expression sug-
gests that FT SchuS4 is not targeting the TLR4 molecule
directly but rather downstream in the signaling cascade,
such as an adaptor protein(s) or transcription factor(s).
One possibility is that Francisella is targeting either the
MyD88—dependent or MyD88-independent (TRIF-
dependent) arms of the TLR4 pathway, which each result
in the activation of specific transcription factors [20, 21].
To define the contribution of each adaptor protein in
LPS-induced gene expression in the lungs, groups of
four wild-type, MyD88−/− and TRIF−/− C57BL/6 micewere exposed to aerosolized E. coli LPS or aerosolized
PBS. For each microarray experiment, RNA from E. coli
LPS-treated animals was compared with RNA from the
PBS-mice of the same genetic line (e.g.. TRIF−/− after
aerosolized LPS versus TRIF−/− after aerosolized PBS).
Sequences showing increased expression in wild-type
mice exposed to E. coli LPS relative to PBS-treated
were used as a reference to identify a comprehensive
list of LPS-responsive genes in the C57BL/6 back-
ground. The profiles of these sequences were then
assessed in each of the knockout strains to define
MyD88 and TRIF-dependent gene expression. The
absence of the MyD88 adaptor protein exhibited a
much greater impact on expression of LPS-responsive
sequences than TRIF, as evidenced by the absence or
reduced expression of a large number of sequences in
the MyD88−/− animals compared to wild-type animals
(Additional file 4: Figure S1A). This is consistent with
MyD88 being particularly important for initiating host
response to Gram-negative bacterial infections [25]. A
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dependent on the presence of TRIF, as shown by their
lack of expression in TRIF−/− mice (Additional file 4:
Figure S1A).
The expression profiles of LPS-responsive sequences
that were not suppressed, partially suppressed or sup-
pressed by Francisella infection were then assessed in
each of the knockout strains. For this analysis, only LPS-
responsive genes (n = 471) commonly induced in both
BALB/c and C57BL/6 mice were used due to differences
in the transcriptional response to E. coli LPS between
these two strains (data not shown). Most LPS-inducible
genes not affected by Francisella infection did not show
increased expression in the MyD88−/− mice, indicating
that their expression is dependent on the presence of
MyD88 (Additional file 4: Figure S1B). Similarly, the ma-
jority of LPS-responsive genes that were partially or
completely suppressed by FT SchuS4 were also
dependent on MyD88. None of the sequences appeared
to be completely dependent on the presence of TRIF, as
evidenced by their induction in TRIF −/− mice exposed
to E. coli LPS. This is likely due to the small number of
TRIF-dependent genes in general, making it difficult to
assess the role this adaptor molecule may play in Franci-
sella-mediated suppression. Collectively, these data dem-
onstrate attenuation of only a subset of MyD88-
dependent genes in the presence of Francisella infection,
making it unlikely that MyD88 is directly targeted in
which case all MyD88-dependent genes would be ex-
pected to be affected.
Upstream analysis of E. coli LPS-responsive gene
expression identifies potential targets antagonized by F.
tularensis infection
oPOSSUM, a web-based system for the detection of
over-represented conserved transcription factor (TF)
binding sites in sets of genes [26, 27], was used to iden-
tify candidate transcription regulators that may be tar-
geted by Francisella based on the expression profiles of
their target genes. The results of the oPOSSUM analysis
of the 972 genes showing increased expression in lung
tissue from animals exposed to aerosolized E. coli LPS
showed significant enrichment of the binding sites for
43 TFs (Table 1 and Fig. 3). These included key TFs
known to be activated by the TLR4 signaling cascade
(AP1, IRF1 and 2, NFκβ1, Rel, RelA, Sp1, Stat1) in
addition to numerous factors not previously associated
with this pathway.
Binding sites for 27 of these 43 TFs were also over-
represented in LPS-responsive genes suppressed by
Francisella infection, suggesting that their activity may
be perturbed in the presence of bacteria (Table 1 and
Fig. 3). This included numerous members of the fork-
head family of TFs, implicated in a wide range of cellularfunctions including modulating inflammatory responses
by antagonizing pro-inflammatory transcriptional activ-
ities (FoxA2, FoxD1, FoxO3), lymphoid homeostasis
(FoxO3), immunosuppressive properties of T regulatory
cells (FoxA1), suppressing Th2 immunity (FoxA2), NK
cell function (Foxq1) and acute lung injury (FoxA1).
Since many of these TFs function to repress transcrip-
tion of their target genes, the binding site enrichment
may actually indicate activation by Francisella. In sup-
port of this, the expression levels of Foxf2, Foxa2, Foxd1
and Foxd3 were all increased in FT SchuS4 and FT
SchuS4 + E.coli LPS treated mice, but not in E. coli LPS-
treated control animals, nor were they induced in FN or
LVS-infected animals exposed to E. coli LPS (data not
shown). The binding site for IRF1 was also over-
represented in this group, consistent with a previous re-
port showing inhibition of nuclear translocation of this
TF by Francisella [10]. Other candidate regulators in-
cluded numerous TF involved in immune cell differenti-
ation/proliferation (NFIl3, Sox5, Sox9, Plag1, CEBPA,
Gata1, Arid3A), immune cell infiltration (Pax6, Hoxa5)
and dampening inflammation (Prrx2, Pdx1).
Interestingly, binding sites for NfKappaB, Rel and
RelA, part of the key TF complex activated via MyD88
signaling, were overrepresented only in sequences that
were either not suppressed or partially suppressed by
Francisella infection (Table 1). This is consistent with
the data showing that many MyD88-dependent genes
are not suppressed during infection and suggests the
bacteria only partially blocks activation of this important
inflammatory transcription complex. Binding sites for
STAT1, SP1B, and NFATC2 were also overrepresented
in LPS-responsive gene expression unaffected by the
presence of Francisella. This analysis suggests that Fran-
cisella may not significantly impact the activity of the
main transcription factors known to be activated as a re-
sult of TLR4 engagement and subsequent signaling cas-
cade. However, it identified numerous other potential
candidate TF, possibly functioning downstream of the
immediate TLR4 signaling cascade, that may be per-
turbed by Francisella infection to mediate antagonism of
host immune responses.
Expression of key inflammatory mediators is not
antagonized by Francisella
To gain insight into which LPS-associated cellular
processes are perturbed by FT SchuS4, gene ontology ana-
lysis of LPS-responsive genes that were i) not suppressed,
ii) partially suppressed or iii) suppressed by Francisella in-
fection was performed. As expected, analysis of all LPS-
inducible sequences (n = 978) showed enrichment for
genes predominantly involved in host defense responses,
including hematological system, immune cell trafficking,
inflammatory response, lymphoid tissue structure and
Table 1 oPOSSUM 3.0 results for LPS-induced genes suppressed, not suppressed or partially suppressed by F. tularenesis




















AP1 Leucine Zipper 5.492 49.37 0.0004501
Ar Hormone-nuclear
Receptor
9.599 8.988 0 7.618 7.526 5.36E-10
ARID3A Arid 18.069 53.054 0 20.009 38.878 0 6.948 15.813 2.65E-07
CEBPA Leucine Zipper 17.508 56.795 0 7.313 24.871 5.02E-09 7.727 19.6 1.11E-09
Egr1 BetaBetaAlph-zinc
finger
9.242 35.76 0 10.597 15.075 0
FOXA1 Forkhead 9.272 46.98 0 9.751 29.455 0
Foxa2 Forkhead 7.135 47.333 1.38E-08 12.479 41.802 0
FOXD1 Forkhead 13.729 53.842 0 14.463 39.964 0
Foxd3 Forkhead 17.779 49.257 0 15.734 40.563 0
FOXF2 Forkhead 6.49 20.958 1.10E-06 7.19 21.679 1.20E-08
FOXI2 Forkhead 14.135 36.86 0 16.058 36.651 0
FOXO3 Forkhead 14.321 50.651 0 12.83 37.983 0 5.324 14.497 0.003402
Foxq1 Forkhead 10.523 44.105 0 11.804 42.968 0
Gatal GATA 9.843 45.572 0 6.597 31.379 7.22E-07 0.013187
Gfi BetaBetaAlpha-zinc
finger
12.107 48.885 0 7.9 15.946 3.61E-10
HLF Leucine Zipper 11.858 24.551 0
HOXAS Homeo 19.619 55.444 0 20.668 35.237 0 5.306 16.325 0.003501
IRFI IRF 16.593 37.42 0 11.588 30.497 0 6.563 11.061 2.93E-06
IRF2 IRF 10.478 10.828 0
Lhx3 Homeo 10.204 21.206 0 15.823 27.512 0
MEF2A MADS 11.261 28.869 0 5.667 22.212 0.000234 5.164 9.596 0.007108
MIZF BetaBetaAlpha-zinc
finger
5.96 15.897 3.14E-05 8.243 20.427 4.82E-12
NFATC2 Rel 7.841 54.491 6.71E-11 7.61 8.397 1.70E-
09
NFE2L2 Leucine Zipper 5.901 27.696 4.39E-05
NFIL3 Leucine Zipper 14.295 38.826 0 9.437 35.141 0
NF-
kappaB
Rel 13.665 56.778 0 39.032 14.744 0 5.492 16.553 0.001656
NFKB1 Rel 5.708 14.056 0.0001325
Nkx2-5 Homeo 22.118 58.941 0 26.88 44.266 0
NKX3-1 Homeo 15.244 41.36 0 17.48 37.027 0
Nobox Homeo 9.798 46.489 0 12.618 43.858 0
Pax6 Homeo 6.502 10.168 1.04E-06 10.422 16.405 0




Pou5fl Homeo 6.767 12.53 1.77E-07
Pnx2 Homeo 14.121 49.554 0 18.221 38.381 0
REL Rel 11.771 55.54 0 30.632 10.072 0 5.323 11.424 0.003402
RELA Rel 13.26 45.068 0 42.057 16.996 0 5.945 9.196 0.000138
Sox5 High Mobility Group 15.026 49.598 0 18.695 46.646 0 5.001 15.29 0.013577
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Table 1 oPOSSUM 3.0 results for LPS-induced genes suppressed, not suppressed or partially suppressed by F. tularenesis (Continued)
SOX9 High Mobility Group 8.54 45.725 0 12.388 30.748 0
SPIB Ets 5.794 74.595 8.15E-05 9.177 7.168 0
SRF MADS 8.106 8.71 6.92E-12
STAT1 Stat 6.86 30.655 9.53E-08 20.574 7.325 0
TBP TATA-binding 14.562 52.455 0 11.841 43.297 0 7.908 14.859 3.61E-10
Background: All 29,347 genes in oPOSSUM database, Conservation: 0.4, Matric Threshold: 85 %, Search region +/−2000 bp. Q-value represents FDR
adjusted p-values
Walters et al. BMC Genomics  (2015) 16:874 Page 9 of 16infectious disease (Fig. 4a). Enriched canonical pathways
included classic pro-inflammatory signaling such as NF-
κβ, IL6 and TLR pathways (Fig. 4a).
Surprisingly, LPS-responsive sequences not suppressed
by Francisella infection were also predominately enriched
for genes related to classic pro-inflammatory signaling
(Fig. 4b). This included numerous genes associated with
NFκβ/TLR signaling (NFkb2, Nfkbia, Nfkbie, NFkbiz,
Nod2, RelB, Map3k8, MyD88, Ripk2, Irak3, Tifa) as well
as the majority of pro-inflammatory chemokines/cyto-
kines induced by E.coli LPS (including Ccl2, Ccl3, Ccl4,
Ccl7, Ccl9, Ccl17, Ccl19, IL1a, IL1b, Cxcl3, Cxcl5, Cxcl9).
While this is consistent with the enrichment of NF-κβ TFFig. 3 Network of transcription factors predicted to regulate E. coli LPS-resp
TFs with binding sites overrepresented in genes altered (suppressed or par
and pink, respectively. Lines indicate direct interaction: For visualization, nobinding sites in this gene set, it is intriguing that these
genes are not antagonized, at least at the level of transcrip-
tion, as they play a key role in both recruiting and activat-
ing immune cells critical for successful clearance of
Francisella. Many genes induced by inflammatory cyto-
kines (SelE, Saa1, Saa2, Vacm1, Vnn3, Socs3) were also
not suppressed, suggesting that endothelial/epithelial cells
are responding to actions of these cytokines. The lack of
suppression of genes known to play a role in dampening
inflammation (Zc3hl2a, Irg1, Irak3, Il1r2, Il1rn, Tyrobp,
Lilb4) suggests the bacterium may be utilizing host path-
ways to suppress immune responses. Targeting host pro-
cesses responsible for regulating immune homeostasis isonsive gene expression based on overrepresentation of binding sites.
tially suppressed) by F. tularensis SchuS4 infection are indicated in red
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Fig. 4 Functional annotation of E. coli LPS-responsive gene expression in the absence and presence of F. tularensis SchuS4 infection. Top scoring
functional categories and canonical pathways are shown for all LPS-inducible genes (a) LPS-inducible genes not suppressed (b) partially
suppressed (c) or suppressed (d) by Francisella infection
Walters et al. BMC Genomics  (2015) 16:874 Page 10 of 16an effective way of preventing host responses that are det-
rimental to the survival of pathogens. Indeed, Irg1 inhibits
TLR-triggered production of IL-6 and TNFα, both of
which are the only two pro-inflammatory cytokines that
are partially suppressed during infection.Perturbation of innate antiviral defense responses, gene
transcription, intracellular trafficking and actin
cytoskeleton by Francisella infection
LPS-response sequences that are partially suppressed by
Francisella infection were also enriched for genes which
Walters et al. BMC Genomics  (2015) 16:874 Page 11 of 16function in directly in mediating inflammation but the
specific functions were generally different than those
unaffected by Francisella (Fig. 4c). Many are involved in
innate antiviral responses (Ifi203, Ifih1, Ifitm2, Ifitm6,
Ifngr2, IRF5, Ddx58, Ddx60, Trim6, Trim56, lamp3,
Trim30d). Although only two prominent inflammatory
cytokines (IL6 and TNFα), two chemokines (Cxcl1,
Cxcl2) and TFs (Mef2a, Stat3, Nfκβ-1, IRF5, Nfκβid)
were partially suppressed, there were many genes related
to activation of IL8 signaling, including the receptor
Cxcr2. While LPS-induced expression of mouse IL8
homologues Cxcl1/Cxcl2 [28] were partially suppressed,
they were still very highly induced in FT SchuS4-
infected animals (>100-fold). The other IL8 homologue,
CXCL5, was induced to extremely high levels (approxi-
mately 400-fold) in FT SchuS4-LPS-expsed animals,
compared to approximately 200-fold in LPS-exposed
control animals. The IL8 pathway can trigger neutrophil
chemotaxis, respiratory burst, granule release and also
increase adhesion [29]. Partial suppression of genes en-
coding proteins involved in differentiation/function of
macrophages/monocytes (Cx3cr1, Lyz2) and neutrophils
(Lcn2, Ly6a, Lyz2, Nab1) indicate the bacterium may be
antagonizing these immune cells in mechanisms inde-
pendent of blocking their recruitment. Others were as-
sociated with glucocorticoid receptor signaling (such as
Nr3c1, Ptgs2, Creb, Pik3c2a, Pik3R1,Gmeb2), which also
includes genes from NFkappaB (NF-κβ1, Ascc1, Erc1,
Map3k2) and TNF signaling (Tnfrsf11a, TNF-α). Activa-
tion of this pathway can either repress transcription of
inflammatory genes via inhibition of AP1, NF-κβ and
NF-AT nuclear translocation, or induce anti-
inflammatory gene expression.
Interestingly, many genes partially suppressed by Franci-
sella infection are associated with intracellular trafficking,
including multiple Rab proteins (Rab1, Rab11a, Rab11fip2,
Rab28). The Rab11a GTPase controls TLR4-induced acti-
vation of IRF3 [30] which may contribute to the reduced
expression of numerous IFN-induced sequences observed
in infected mice. Genes essential for trafficking of lyso-
somal enzymes (Gnptab, Trim23, Trim30d, Vma21),
transport of cargo through the golgi apparatus (Golim4,
Golph3, Vps35, Synrg), endoplasmic reticulum (Sec13,
Sec22a, Sec63) and general intracellular trafficking (Arcn1,
Exosc1) were also modulated in presence of infection. As
an intracellular pathogen, Francisella is known to modu-
late intracellular trafficking, including impairment of
phagosome maturation and disrupting the vesicle mem-
brane to escape into cytosol [31].
Gene ontology analysis of LPS-responsive gene expres-
sion completely inhibited by Francisella infection showed
greater representation of fundamental cellular processes
such as gene expression, post-translational modification,
and cell injury (Fig. 4d). Gene expression-related processesinvolved chromatin modification, including histones
(Hist1hle, Hist1h2ab, Hist1h4d, Hist1h4f, Hist2h4,
Hist4h4) and chromodomain helicases (Chd1, Chd4,
Chd6, Chd9), which controls access of the transcription
complex to DNA. The expression levels of genes involved
in mRNA processing, such as editing/splicing (Celf2,
Cpeb4, Ddx23, Prpf4og, U2af2, Sf3b1, Tra2b), stability
(Csdel, Ddx6, Smg1) and export (Hnrnpao, Hnrnpr) were
also significantly decreased in the presence of infection, as
were many genes involved in transcription initiation. This
may explain the global decrease in cellular gene expres-
sion observed during acute F. tularensis infection [23]. In-
hibition of numerous genes related to ubiquitin
modification of proteins, including E3 ubiquitin-ligases
(Cbll1, Hecd1, Huwel, Urb2, Urb3), ubiquitin-conjugating
enzymes (Ube2k, Ube2w) and ubiquitin-specific pepti-
dases (Usp15, Usp47) suggest post-translational modifica-
tion mechanisms is also an important target of F.
tularensis.
LPS-responsive gene expression associated with cell
growth/proliferation also appeared to be particularly tar-
geted by F. tularensis, including those associated with
the eIF4/p70 SK6 pathway (eIF2, eIF4EBP2, Itga4,
PPP2R3A, Rn18) which activates the PI3K/AKT path-
ways in response to growth factors and cytokines.
Proliferation-related genes included genes which func-
tion to both inhibit and promote cell growth, making it
difficult to interpret the overall functional effect of this
modulation. The P13K/AKT signaling pathways were
also targeted by F. tularensis, with the expression levels
of Pik3c2a, Pik3cb, Pik3r1, Rapgapa2, Prex2, PTEN,
ccdc88a and Spnb2 all significantly decreased. Multiple
studies have implicated the PI3K/Akt pathway in F.tular-
ensis-mediated suppression of cytokine production, al-
though results suggest both activation and repression of
the pathway occurs [7, 14, 32, 33].
Genes associated with intracellular trafficking, includ-
ing clathrin-mediated enodocytosis (Aak1, Fcho2, Hip1,
Itsn2), phagocytosis (Acap2, Apbblip, Fnbp1l, Rab43),
golgi vesicle trafficking (Arfgapl, Asap2, Cog5, Scfd1,
Atad2b, Lman2), secretory pathway (Pcsk5), receptor in-
ternalization/membrane trafficking (Git2) and vesicle
acidification (Atp6voa4, Atp6voc) were also targeted by
Type A Francisella. Indeed, Francisella has been shown
to prevent acidification of their phagosomes [34]. In
addition, inhibition of cytoskeleton (Clasp1, Ldb3, Lrch3,
Mical2, Pkp4, Svil) and cell motility/adhesion-related
genes (such as Ahnak, Itga2, Itga4, Itgb6, Lgals9, Lpp,
Ptprb, Cd226, Svil, Git2) suggest the bacterium is target-
ing processes responsible for cytoskeleton remodeling
and migration of cells.
Collectively, while Francisella does not appear to
directly inhibit expression of canonical inflammatory me-
diators, it may be targeting cellular processes that
Walters et al. BMC Genomics  (2015) 16:874 Page 12 of 16collectively could dysregulate an effective innate immune
response while at the same time facilitating its own
replication.
Discussion
This study represents the first demonstration that prior
infection with Type A F. tularensis subsp tularensis, not
but F. novicida or F. tularensis subsp holarctica LVS,
substantially alters the pulmonary transcriptional re-
sponse to a TLR4 agonist. These results indicate that the
absence of host defense response-related gene expres-
sion is at least partially attributed to its ability to
antagonize TLR4 signaling. It is consistent with and ex-
pands upon previous reports demonstrating that Type A
F. tularensis can attenuate distinct aspects of host in-
flammatory responses. Specifically, virulent Francisella
can attenuate on-going cytokine responses to less viru-
lent F. novicida in human monocytes [35], partially sup-
press secretion of TNFα and IL12 in response to TLR2
and TLR4 agonists [6], and inhibit the recruitment of in-
flammatory cells throughout the lung in response to
aerosolized LPS [3]. Recently, lipids from virulent
SchuS4, but not attenuated strains, have been found to
partially suppress phenotypic maturation of dendritic
cells, infiltration of inflammatory cells, and select cyto-
kine secretion [10, 36]. However, the host response to
pathogens is both complex and extensive, consisting of
both the cell sensing the presence of the pathogen and
activating defense pathways and the subsequent modula-
tion of these cellular pathways by the pathogen. Examin-
ing the effect of Francisella on a limited number of
inflammatory mediators may not accurately reflect the
overall interplay between the bacteria and innate
immune pathways. The current study uses a global ap-
proach to more clearly define the scope of perturbation
and distinguish between inflammatory genes/pathways
that are specifically targeted by Francisella versus those
that are not.
Due to the challenges of working with highly virulent
Type A strains, F. novicida and F. subsp. holarctica LVS
are often utilized to investigate the interaction of Franci-
sella with innate immune pathways. However, while both
of these strains are capable of causing tularemia in mice
similar to the most virulent type A strains, they rarely
cause serious illness in humans. Their inability to signifi-
cantly alter the transcriptional response to TLR4 ago-
nists suggests inherent differences in their interaction
with immune response pathways. While there is exten-
sive conservation between Francisella species at the
genome level, regions unique to the virulent Type A
strains have been identified [37]. Indeed, important dif-
ferences in the ability to modulate innate immunity have
been demonstrated between virulent and avirulent
strains of Francisella. For example, while both F.tularensis SchuS4 ΔpyrF and LVS ΔpyrF strains are defi-
cient for intramacrophage growth, LVS ΔpyrF induces
significantly higher levels of TNF-α than wild-type LVS
in exposed macrophages whereas SchuS4 ΔpyrF does
not, suggesting it has additional mechanisms for attenu-
ating cytokine expression in macrophages compared to
LVS [12]. Induction of MiR-155 by F. novicida, but not
the virulent Type A SchuS4 strain, has been linked to
SHIP down-regulation and enhanced pro-inflammatory
cytokine response [38]. TNF-α mediated nuclear trans-
location of NF-κβ p65 subunit is partially blocked by
SchuS4 but not LVS infection [7]. Collectively, these
studies demonstrate the importance of utilizing SchuS4
when investigating modulation of inflammatory path-
ways by virulent Francisella.
Surprisingly, although Type A F. tularensis subsp.
tularensis infection significantly altered the host tran-
scriptional response to E.coli LPS, mRNA levels of the
majority of the classical inflammatory mediators were ei-
ther unaffected or only partially suppressed. These in-
clude genes encoding critical signaling molecules (such
as TLR2, MyD88, Map3K8) and transcription factors
(JunB, Myc, Fos, NF-κβ). Key inflammatory chemokines
responsible for recruiting immune cells, including Ccl2,
Ccl9, Cxcl2, Cxcl3, Il1b and numerous others, were in-
duced to either an equivalent level or even higher in
Francisella-infected animals exposed to E. coli LPS rela-
tive to similarly treated control animals. The expression
of many pro-inflammatory mediators is regulated by
MyD88 [21], consistent with data from the current study
demonstrating that many MyD88-dependent genes are
not actively suppressed by the bacterium. Only expres-
sion of TNFα and IL6 was partially inhibited in infected
animals, suggesting that the suppression of pro-
inflammatory cytokine expression is not as global as pre-
viously thought and instead may be restricted to a sub-
set. Interestingly, most inflammatory-related gene
expression suppressed (or partially suppressed) by F.
tularensis is more associated with viral infection and
host antiviral responses, including many known to be in-
duced in response to interferon and/or involved in cell
entry of numerous viruses. As a predominantly intracel-
lular pathogen, these genes may play a role in as yet
undefined anti-bacterial processes.
The lack of pro-inflammatory cytokine gene expres-
sion observed during acute F. tularensis infection may
be more due to lack of recognition as opposed to active
targeting of pathways by the bacteria. However, it is also
possible that F. tularensis utilizes post-transcriptional
mechanisms to inhibit cytokine production and subse-
quent immune cell infiltration. Many of the genes antag-
onized by F. tularensis encode proteins with roles in
various intracellular trafficking activities and actin cyto-
skeleton rearrangement. Intracellular trafficking
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gen processing, cytokine/TLR receptor trafficking, cyto-
kine secretion, and endothelial membrane re-
organization to facilitate immune cell extravasation. In-
deed, targeting intracellular trafficking pathways has
been proposed for anti-inflammatory drug development
[39]. Similarly, remodeling of the actin cytoskeleton is
essential for many cellular processes involved in innate
immune responses, including phagocytosis and chemo-
taxis of macrophages (and other immune cells) [40], and
gene expression [41]. A recent report demonstrates that
actin polymerization plays a critical role in limiting Sal-
monella replication within macrophages [42]. Not sur-
prisingly, intracellular pathogens employ mechanisms to
subvert the host cell cytoskeleton and promote their
own survival (reviewed in [43]), such as the effector pro-
teins encoded by Yersinia spp. which target the actin
cytoskeleton to disrupt the phagocytic machinery of in-
fected cell [44]. As an intracellular pathogen, F. tularen-
sis utilizes both intracellular trafficking and remodeling
of actin cytoskeleton to gain entry into cells. It enters
macrophages via a novel process of engulfment by trig-
gering formation of pseudopod loops utilizing comple-
ment and complement receptors [45]. It then modulates
the biogenesis of the phagosome, preventing its acidifi-
cation and fusion with lysosomes, to facilitate its release
into the cytosol [34, 46]. It is possible that once released
into the cytosol, F. tularensis targets intracellular traffick-
ing and/or actin cytoskeleton to attenuate host responses
which are detrimental to its survival. While it is known
that F. tularensis infection blocks expression of an activa-
tion marker in dendritic cells [3], no study has yet investi-
gated the effects on dendritic cell/macrophage functions
including phagocytosis and antigen presentation.
That the expression of many E.coli LPS-responsive
genes remains unaffected by F. tularensis infection sug-
gests that the target is not the TLR4 receptor but rather
downstream in the signaling pathway. The levels of
TLR4 mRNA did not increase significantly in response
to any of the Francisella strains relative to control ani-
mals. Exposure of FT SchuS4-infected animals to E. coli
LPS resulted in increased expression of many MyD88-
dependent genes, suggesting that this adaptor protein is
not directly targeted by the bacteria. MyD88 mRNA
levels increased approximately 2-fold in response to FT
SchuS4 exposure alone, further increasing to 6.5-fold
following E. coli LPS exposure. It is also unlikely that
TRIF is a direct target given the relatively few genes that
are strictly dependent on this adaptor protein and the
extensive number of genes suppressed by F. tularensis.
Like TLR4, TRIF mRNA levels did not increase in re-
sponse to any of the Francisella strains. While it is pos-
sible that F. tularensis is antagonizing the activation of
an alternative receptor/signaling pathway that is bindingE. coli LPS, TLR4 is the central component of the LPS
sensor (reviewed in [47]). Absence of TLR4 abolishes re-
sponse to LPS, although cross-talk between TLR4 and
TLR2 can augment this response [48]. More recently, it
was shown that intracellular LPS can trigger, via an un-
known mechanism, caspase-11 activation by the non-
canonical inflammasome, although this requires prior
stimulation with either LPS, poly (I:C), or interferons
[49, 50]. Caspase-11 induces pyroptosis, a form of pro-
grammed cell death that defends against intracellular
pathogens. F. novicida evades caspase-11 activation pre-
sumably through its unique tetra-acylated lipid A [49],
but it is not known if a similar phenomenon occurs with
virulent F. tularensis strains nor is it known if this path-
way is actively inhibited. Targeting of signaling triggered
by endogenous TLR4 ligands (such as HMGB1, heparan
sulfate, heat shock proteins) is also a possibility,
although there is uncertainty to whether these are true
ligands [51].
The lack of enrichment of binding sites for the main
TF activated by TLR4 signaling, including NFKB, SP1,
Rel/RelA, in LPS-responsive genes suppressed by FT
SchuS4 was surprising and suggests that the bacteria is
targeting downstream of the immediate TLR4 signaling
cascade. Overrepresentation of the binding sites for the
TFs Mef2a, IRF1, CEBPA, FoxO3, HoxA5, and TBP in E.
coli LPS-responsive genes that were inhibited in the
presence of F. tularensis (either completely or partially)
suggests their activity is modulated. While the expres-
sion levels of Mef2a and TBP were reduced in the pres-
ence of F. tularensis (data not shown), the others
showed similar expression levels to E. coli LPS-treated
control animals, suggesting that their activity is being
modulated at the post-transcriptional level similar to
what has been demonstrated for IRF1/IRF8 [10] . The
expression levels of other putative transcription factors
were also decreased in the presence of infection (data
not shown), including many not previously linked to in-
flammation. Investigating the DNA binding capacity of
these TF in the presence and absence of F. tularensis in-
fection will more clearly define whether their activity is
modulated by the bacteria and may also identify novel
regulators of inflammation.
While inhibition of the pulmonary transcriptional
response to E. coli LPS was observed at the level of
whole lung, it is possible that F. tularensis differentially
targets immune pathways in specific cell types. The ma-
jority of studies investigating the modulation of innate
immune responses by F. tularensis have focused on mac-
rophages and dendritic cells, the predominant infected
cell type during acute infection [52]. However, the bac-
terium is capable of infecting multiple cell types in the
lung following pulmonary exposure, including mono-
cytes, neutrophils, alveolar type II epithelial cells [52]
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related adaptor proteins to varying levels [25, 54, 55]. Cell-
type specific regulation of LPS-induced TLR4 signaling in
the lungs is modified by microenvironmental factors in-
cluding pulmonary surfactants and spatiotemporal
localization of TLR4 receptor, co-receptors and adaptors
(reviewed in [25]). It has been suggested that this differen-
tial regulation is important in coordinating responses to
inhaled pathogens [56]. F. tularensis could target any of
these regulatory mechanisms that fine-tune LPS signaling
and may do so in a cell type-specific manner. For cell
types that are the primary target for F. tularensis replica-
tion, including macrophages, antagonism of immune re-
sponses may be mediated primarily by factors present
during bacterial replication, as suggested by the data in
the current study. For cell types that are not the primary
target but play a key role in activation of innate immune
responses, such as lung epithelial and endothelial cells, the
bacteria may utilize a secreted factor to suppress these
critical responses as has been proposed [6]. Because of the
likelihood of cell-type specific TLR4-mediated gene ex-
pression patterns, further studies are required to help de-
fine immune pathways that are targeted by F. tularensis in
different cell types and determine whether these pathways
are targeted by a secreted bacterial factor or factors
present during intracellular bacterial replication.
Conclusions
The present study has demonstrated that Francisella is
capable of significantly modulating the transcriptional
response to an endogenous TLR4 agonist. Thus the lack
of inflammatory gene expression observed during acute
infection is at least partially attributed to active suppres-
sion of this important pathway. This modulation was re-
stricted to the highly virulent F. tularensis FT SchuS4
strain, highlighting the importance of using this strain
when studying the interaction of virulent Francisella and
innate immune responses. Analysis of genes inhibited by
Francisella suggests perturbation of cellular processes
including intracellular trafficking and actin cytoskeleton
may broadly impact an effective innate immune
response.
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